Reports

Amgen, Hospira and Sandoz set to dominate US biosimilars market

Home/Reports | Posted 31/05/2013

A new report released by Thomson Reuters on 14 May 2013 identifies Amgen, Hospira and Sandoz as having the greatest potential to dominate the early stages of the biosimilars market in the US.

US places India on IP black list

Home/Reports | Posted 17/05/2013

The US has placed India on a special trade black list of countries that have raised concerns about intellectual property rights.

Use of biosimilars in Europe

Home/Reports | Posted 10/05/2013

Uptake of biosimilars in Europe is slowly increasing, according to a new report published by the European Commission’s (EC) Enterprise and Industry Directorate-General.

EU publishes consensus report on biosimilars

Home/Reports | Posted 03/05/2013

The European Commission’s (EC’s) Enterprise and Industry Directorate-General has published a new report providing comprehensive information on the concept of biosimilars.

More UK patients affected by drug shortages in 2012

Home/Reports | Posted 29/04/2013

The number of UK patients affected by shortages in brand-name medicines has increased during 2012, according to an online survey carried out by pharmacists’ organization Chemist+Druggist (C+D).

Patients in US turn to generics to save money

Home/Reports | Posted 19/04/2013

According to a new report released on 9 April 2013 by the US Centers for Disease Control and Prevention, adults in the US used several strategies to reduce the costs of their medications, including asking their doctor for a lower-cost (generic) medicine.

Huge differences in prescription drug prices in Ireland

Home/Reports | Posted 05/04/2013

A survey carried out by Ireland’s National Consumer Agency (NCA) has found that the price of many commonly prescribed medicines varies widely across Ireland.

Fewer generics approved in the US during 2012

Home/Reports | Posted 15/03/2013

FDA approved fewer generics for the US market during 2012 than in 2011, according to a new report from Thomson Reuters.

India supplies 20% of generic drugs worldwide

Home/Reports | Posted 01/03/2013

Every fifth tablet, capsule and injectable generic drug being used in the world is manufactured in India, according to India’s Health Minister Ghulam Nabi Azad.

Inequality in Europe over access to biologicals for arthritis

Home/Reports | Posted 15/02/2013

Data from a study presented at the European League Against Rheumatism’s Annual European Congress of Rheumatology, EULAR Congress 2012, demonstrates the vast inequalities in access to biologicals for the treatments of rheumatoid arthritis across 46 European countries [1, 2].